In the murine tumor TIL therapy model, CD8+CD39-CD69- T cells could significantly suppress the tumor growth and prolong the survival of the mice to provide potential cure comparing to CD8+CD39+CD69+ T cells. The gene discussed is CD69; the disease is neoplasm.